Connect your AI

Hamilton Lane HLNE Issuance of warrants to purchase common stock

Issuance of warrants to purchase common stock at other companies

Oruka Therapeutics, Inc.ORKA

$2.52M-75.7%

NovaGold ResourcesNG

$9.9M—

KEE

Keel Infrastructure Corp. Common StockKEEL

$11.48M—

ADMA BiologicsADMA

$1.4M—

ADMA BiologicsADMA

$1.4M—

Oruka Therapeutics, Inc.ORKA

$2.52M-75.7%

Other financials

Income statement

Revenue$193.6M-2.2%

Net income$66.2M+31.0%

EPS (diluted)$1.48+9.4%

Balance sheet

Cash & equivalents$348.0M+6.3%

Total debt$356.5M-3.2%

Total equity$915.2M+27.6%

Total assets$2.3B+36.4%

Cash flow

Operating cash flow$103.0M+162%

CapEx$1.7M-49.3%

Free cash flow$101.2M+182%

Valuation

Market cap$3.3B-32.2%

Profitability

Net margin32.8%+2.3pp

FCF margin55.2%+14.7pp

Returns & leverage

Return on equity30.5%-4.5pp

Debt / equity0.4×-0.1×

Where this comes from

Reported directly by Hamilton Lane in its filing.

Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued.

The official record: Hamilton Lane’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Hamilton Lane's issuance of warrants to purchase common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Hamilton Lane's issuance of warrants to purchase common stock?: Hamilton Lane (HLNE) reported issuance of warrants to purchase common stock of $8.37M in Q4 2025.